Ashley Knights

849 total citations
15 papers, 705 citations indexed

About

Ashley Knights is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Ashley Knights has authored 15 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Ashley Knights's work include Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). Ashley Knights is often cited by papers focused on Immunotherapy and Immune Responses (12 papers), T-cell and B-cell Immunology (6 papers) and CAR-T cell therapy research (5 papers). Ashley Knights collaborates with scholars based in Australia, Germany and Switzerland. Ashley Knights's co-authors include Alexander Knuth, Alfred Zippelius, Laura Strauss, Christoph Bergmann, Theresa L. Whiteside, Jonathan Cebon, Weisan Chen, Katherine Woods, Anupama Pasam and Graham Pawelec and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

Ashley Knights

15 papers receiving 698 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashley Knights Australia 13 498 322 269 47 37 15 705
Sarah S. Gabriel Australia 9 537 1.1× 368 1.1× 193 0.7× 36 0.8× 25 0.7× 14 746
Stephanie Silveria United States 5 472 0.9× 328 1.0× 223 0.8× 32 0.7× 22 0.6× 6 723
Atsuko Sakata Japan 11 660 1.3× 149 0.5× 380 1.4× 25 0.5× 40 1.1× 20 850
Rinako Nakagawa United Kingdom 15 390 0.8× 94 0.3× 319 1.2× 29 0.6× 28 0.8× 24 719
Isabel Maleno Spain 20 753 1.5× 488 1.5× 175 0.7× 42 0.9× 28 0.8× 21 927
Yun Hee Cho United States 7 436 0.9× 100 0.3× 123 0.5× 15 0.3× 46 1.2× 9 581
Laura McOlash United States 13 263 0.5× 426 1.3× 123 0.5× 73 1.6× 20 0.5× 15 661
Dawn K. Schirm United States 8 588 1.2× 264 0.8× 76 0.3× 169 3.6× 11 0.3× 8 711
Qingsheng Li China 10 270 0.5× 187 0.6× 216 0.8× 48 1.0× 49 1.3× 20 556
Béatrice Zitti Italy 14 596 1.2× 224 0.7× 171 0.6× 56 1.2× 33 0.9× 15 752

Countries citing papers authored by Ashley Knights

Since Specialization
Citations

This map shows the geographic impact of Ashley Knights's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashley Knights with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashley Knights more than expected).

Fields of papers citing papers by Ashley Knights

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashley Knights. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashley Knights. The network helps show where Ashley Knights may publish in the future.

Co-authorship network of co-authors of Ashley Knights

This figure shows the co-authorship network connecting the top 25 collaborators of Ashley Knights. A scholar is included among the top collaborators of Ashley Knights based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashley Knights. Ashley Knights is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bethune, Michael T., Xiaohua Li, Jiaji Yu, et al.. (2018). Isolation and characterization of NY-ESO-1–specific T cell receptors restricted on various MHC molecules. Proceedings of the National Academy of Sciences. 115(45). E10702–E10711. 53 indexed citations
2.
Woods, Katherine, Ashley Knights, Matthew Anaka, et al.. (2016). Mismatch in epitope specificities between IFNγ inflamed and uninflamed conditions leads to escape from T lymphocyte killing in melanoma. Journal for ImmunoTherapy of Cancer. 4(1). 10–10. 22 indexed citations
3.
Vella, Laura J., Anupama Pasam, Nektaria Dimopoulos, et al.. (2014). MEK Inhibition, Alone or in Combination with BRAF Inhibition, Affects Multiple Functions of Isolated Normal Human Lymphocytes and Dendritic Cells. Cancer Immunology Research. 2(4). 351–360. 116 indexed citations
4.
Vella, Laura J., Anupama Pasam, Nektaria Dimopoulos, et al.. (2013). MEK inhibition, alone or in combination with BRAF inhibition, impairs multiple functions of isolated normal human lymphocytes and dendritic cells. Journal for ImmunoTherapy of Cancer. 1(S1). 6 indexed citations
5.
Knights, Ashley, Jitka Fučíková, Anupama Pasam, Sandra Koernig, & Jonathan Cebon. (2012). Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy. Cancer Immunology Immunotherapy. 62(2). 321–335. 27 indexed citations
6.
Mifsud, Nicole A., Kun Xiao, Heather Jackson, et al.. (2012). A Novel HLA-B18 Restricted CD8+ T Cell Epitope Is Efficiently Cross-Presented by Dendritic Cells from Soluble Tumor Antigen. PLoS ONE. 7(9). e44707–e44707. 7 indexed citations
7.
Klein, Oliver, Christopher Schmidt, Ashley Knights, et al.. (2011). Melanoma vaccines: developments over the past 10 years. Expert Review of Vaccines. 10(6). 853–873. 27 indexed citations
8.
Cebon, Jonathan, Ashley Knights, Lisa M. Ebert, Heather Jackson, & Weisan Chen. (2010). Evaluation of cellular immune responses in cancer vaccine recipients: lessons from NY-ESO-1. Expert Review of Vaccines. 9(6). 617–629. 16 indexed citations
9.
10.
Knights, Ashley, Natko Nuber, Olga de la Rosa, et al.. (2008). Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patients. Cancer Immunology Immunotherapy. 58(3). 325–338. 26 indexed citations
11.
Strauss, Laura, Theresa L. Whiteside, Ashley Knights, et al.. (2007). Selective Survival of Naturally Occurring Human CD4+CD25+Foxp3+ Regulatory T Cells Cultured with Rapamycin. The Journal of Immunology. 178(1). 320–329. 282 indexed citations
12.
Knights, Ashley, Graham Pawelec, Catherine Riley, et al.. (2007). HAGE, a cancer/testis antigen with potential for melanoma immunotherapy: identification of several MHC class I/II HAGE-derived immunogenic peptides. Cancer Immunology Immunotherapy. 56(12). 1885–1895. 23 indexed citations
13.
Walton, Senta M., Marco Gerlinger, Olga de la Rosa, et al.. (2006). Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients. The Journal of Immunology. 177(11). 8212–8218. 21 indexed citations
14.
Müller, Ludmila, Ashley Knights, & Graham Pawelec. (2003). Synthetic peptides derived from the Wilms' tumor 1 protein sensitize human T lymphocytes to recognize chronic myelogenous leukemia cells. The Hematology Journal. 4(1). 57–66. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026